Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Cystoscopy and ureteroscopy are diagnostic or therapeutic procedures, usually performed by urologists, or doctors who specialize in diseases of the urinary tract. These procedures use endoscopes to ...

Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...

The simple urine test correctly identified bladder cancer-associated genes in 71 of 77 patients who went on to develop a ...

Bladder cancer is a common urinary tract cancer that can be difficult to detect early because its symptoms often overlap with less serious conditions. Earlier identification could improve treatment ...

If a diagnosis of TCC of the bladder is suspected, urinary cytology followed by white-light cystoscopy of the bladder is performed. Although white-light cystoscopy is reliable in the detection of ...

A new test for bladder cancer could enable GPs to test a urine sample and spare patients the discomfort of a cystoscopy in hospital, according to UCL research published today in Clinical Epigenetics.

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of a new approach to outcome modeling in patients with bladder cancer that undergo a blue light cystoscopy (BLC ®) in ...

Anew and simple urine test has shown promise in detecting bladder cancer with high accuracy, reducing the need for every ...

The Bladder Cancer Treatment Market was valued at USD 5.13 Billion in 2025 and is projected to expand at a 9.2% CAGR from ...